IPCA Laboratories Ltd Share Price

Overview

IPCA Laboratories Ltd share price is currently ₹1,899.16, up by ₹2.87 (0.15%) from its previous closing price of ₹1,896.29. The share price has gained 8.52% over the past month and gained 40.31% over the past year. The stock's 52-week low and high are ₹1,229.64 and ₹1,928.47, respectively. IPCA Laboratories Ltd has a market capitalisation of ₹ 48,490.00 Cr. The share price was last updated on 25 Aug 2026, 12:38 PM IST.

IPCA Laboratories Ltd

IPCALAB

₹0.00

₹2.87

0.15%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 12:38:51 pm IST

Market Data

Open Price

₹1,884.85

Prev. Close

₹1,896.29

₹1,875.25

Day Low

₹1,923.36

Day High

₹1,229.64

52 Week Low

₹1,928.47

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

36.78

Sector PE

42.03

PB Ratio

5.98

Sector PB

5.82

EPS

51.63

Dividend Yield

0.37

Today's Volume

234.848 K

5 Day Avg. Volume

341.488 K

PEG Ratio

0.67

Market Cap.

₹ 48,490.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 600% at ₹6/Share	07-Aug-2026	07-Aug-2026
DividendsFinal Dividend of 200% at ₹2/Share	05-Aug-2025	05-Aug-2025
DividendsInterim Dividend of 200% at ₹2/Share	27-Nov-2024	27-Nov-2024

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
HDFC Mid Cap Fund - Regular Plan - Growth	1.81 Cr	1.81 Cr no change
Kotak Midcap Fund - Regular Plan - Growth	1.23 Cr	1.23 Cr no change
Axis Midcap Fund - Regular Plan - Growth	40.05 Lac	40.05 Lac no change
Nippon India Growth Mid Cap Fund - Growth Option	31.00 Lac	31.00 Lac no change
DSP Midcap Fund - Regular Plan - Growth	29.90 Lac	28.75 Lac (3.84%)

Show all holdings

About IPCA Laboratories Ltd 👋

Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company's products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.